Cipla
Cipla Share Price Chart
Cipla last traded at ₹1,317.40 (2026-10-13). Over the past month the stock moved -4.5%, three months the stock moved -7.1%, year the stock moved -16.4%. Its closing range over 52 weeks is ₹1,192.40 – ₹1,584.40, with the latest close 16.9% below the high.
Closing prices up to 2026-10-13.
About Cipla
Incorporated in 1935, Cipla Ltd is in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and APIs[1]
Geographical Split FY26:[1] One India - 45% North America - 24% One Africa - 15% EMEU - 13% Others - 3%
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Cipla reported sales of ₹7,119.00 crore (+2.3%) and net profit of ₹786.00 crore (-39.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 7,119 | 1,192 | 17.00 | 786.00 | 9.77 |
| Mar 2026 | 6,541 | 955.00 | 15.00 | 543.00 | 6.87 |
| Dec 2025 | 7,074 | 1,255 | 18.00 | 674.00 | 8.37 |
| Sep 2025 | 7,589 | 1,895 | 25.00 | 1,353 | 16.73 |
| Jun 2025 | 6,957 | 1,778 | 26.00 | 1,292 | 16.06 |
| Mar 2025 | 6,730 | 1,538 | 23.00 | 1,214 | 15.13 |
| Dec 2024 | 7,073 | 1,989 | 28.00 | 1,575 | 19.45 |
| Sep 2024 | 7,051 | 1,886 | 27.00 | 1,305 | 16.13 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +5.6% | +7.1% | +9.2% | +3.9% | +7.6% | +0.0% | -2.8% | +2.3% |
| Operating profit growth | +8.8% | +13.8% | +16.9% | +3.6% | +0.5% | -36.9% | -37.9% | -33.0% |
| Net profit growth | +13.0% | +47.5% | +30.3% | +10.0% | +3.7% | -57.2% | -55.3% | -39.2% |
| EPS growth | +15.1% | +48.7% | +30.1% | +10.2% | +3.7% | -57.0% | -54.6% | -39.2% |
| OPM % | 27.0% | 28.0% | 23.0% | 26.0% | 25.0% | 18.0% | 15.0% | 17.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Cipla reported sales of ₹28,163.00 crore (+2.2%) and net profit of ₹3,862.00 crore (-26.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 28,163 | 5,883 | 21.00 | 3,862 | 48.02 |
| Mar 2025 | 27,548 | 7,128 | 26.00 | 5,269 | 65.28 |
| Mar 2024 | 25,774 | 6,291 | 24.00 | 4,154 | 51.05 |
| Mar 2023 | 22,753 | 5,027 | 22.00 | 2,833 | 34.71 |
| Mar 2022 | 21,763 | 4,553 | 21.00 | 2,547 | 31.19 |
| Mar 2021 | 19,160 | 4,252 | 22.00 | 2,389 | 29.82 |
| Mar 2020 | 17,132 | 3,206 | 19.00 | 1,500 | 19.18 |
| Mar 2019 | 16,362 | 3,097 | 19.00 | 1,492 | 18.96 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +8.0% | +4.7% | +11.8% | +13.6% | +4.5% | +13.3% | +6.9% | +2.2% |
| Operating profit growth | +9.6% | +3.5% | +32.6% | +7.1% | +10.4% | +25.1% | +13.3% | -17.5% |
| Net profit growth | +5.3% | +0.5% | +59.3% | +6.6% | +11.2% | +46.6% | +26.8% | -26.7% |
| EPS growth | +8.2% | +1.2% | +55.5% | +4.6% | +11.3% | +47.1% | +27.9% | -26.4% |
| OPM % | 19.0% | 19.0% | 22.0% | 21.0% | 22.0% | 24.0% | 26.0% | 21.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
Cipla is trading at ₹1396, down 16.6% from its 52W high of ₹1672.2, and has delivered 19.5% YoY returns. Recent quarterly results (Mar 2026) show sharp earnings deterioration with OPM contracting to 15% (vs 26% in Jun 2025) and net profit declining 60% QoQ to ₹543 Cr (EPS: ₹6.87 vs ₹16.06), signaling material margin compression despite consistent sales base of ₹6.5–7.6 Cr per quarter. At P/E 29.43 vs industry 45.99, the stock appears reasonably valued, but the earnings cliff and falling ROE (11.2% vs prior-year trend) coupled with mixed technical setup (RSI 45, Tech Score 56.7 in neutral zone) warrant a cautious stance pending earnings recovery.
- Strong cash flow generation (₹3940 Cr OCF in Mar 2026) with OCF-to-NP ratio of 125% demonstrates robust earnings quality and working capital management despite net profit decline
- Fortress balance sheet with minimal leverage (D/E 0.02, borrowings ₹614 Cr on equity base ₹34432 Cr) providing financial flexibility and downside protection in sector downturns
- Sector-leading ranking (91.4 percentile) and top brokerage support (multiple 'Accumulate' and positive post-Q4 calls) indicate institutional conviction despite near-term earnings volatility
- Severe quarterly earnings contraction (Q4 Mar 2026: OPM 15%, NPM 8.3% vs Q2 Jun 2025: OPM 26%, NPM 18.6%; net profit fell 60% QoQ) signals operational/competitive margin pressure or one-time charges not fully explained—requires urgent management clarity on sustainability
- ROCE deteriorated sharply from 23% (Mar 2025) to 17% (Mar 2026), alongside ROE compression to 11.2%, indicating capital deployment efficiency decline and raising questions on organic growth reinvestment returns if margins don't recover
AI-generated analysis for informational purposes only — not SEBI-registered investment advice.
See Full AI Analysis — Free FREE →Latest News
-
Cipla, Vardhaman Textiles and Siemens Energy India shares cross 200 EMA despite weak sentiment
-
Cipla, Vardhaman Textiles and Siemens Energy India shares cross 200 EMA despite weak sentiment
-
Cipla, Vardhaman Textiles and Siemens Energy India shares cross 200 EMA despite weak sentiment
-
Stocks to Watch Today: Gland Pharma, Rail Vikas Nigam, Cipla, Avalon Tech, Ramco Systems, ESDS Software,... - Moneycontrol.com
-
Cipla inches up as its arm partners with Qilu for licensing, supply of QL2107
-
Cipla, Afcom Holdings and Diamond Power Infrastructure to see some action today
-
Stocks to Watch Today: Gland Pharma, Rail Vikas Nigam, Cipla, Avalon Tech, Ramco Systems, ESDS Software,... - Moneycontrol.com
-
Stocks to watch: ITC, Happiest Minds, ICICI Bank, PVR Inox, Cipla & more - Business Standard
-
Stocks to Watch Today, September 1, 2026: Cipla, Titan Biotech, Indo Tech Transformers, E2E Networks and Time Technoplast - scanx.trade
-
Stocks to watch: ITC, Happiest Minds, ICICI Bank, PVR Inox, Cipla & more - Business Standard
Frequently Asked Questions
What is Cipla's current stock price?
Cipla shares were last quoted at ₹1,317.40 (+1.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Cipla?
Cipla has a price-to-earnings (P/E) ratio of 33.49 and a price-to-book (P/B) ratio of 3.20. The industry P/E is 53.33.
What is the 52-week high and low of Cipla?
The 52-week high of Cipla is ₹1,672.20 and the 52-week low is ₹1,165.55.
What is the market cap of Cipla?
The market capitalisation of Cipla is about ₹112,875.68 crore.
How did Cipla perform in its latest quarterly results?
In the latest quarter (Jun 2026), Cipla reported sales of ₹7,119.00 crore (+2.3%) and net profit of ₹786.00 crore (-39.2%), compared with the same quarter last year.
Is Cipla a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Cipla has a 3-year ROE of 15.00%, 3-year profit growth of 10.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Cipla?
Promoters hold about 29.13% of Cipla.
Which sector does Cipla belong to?
Cipla belongs to the Pharmaceuticals & Drugs sector.